Long-term safety in adults with X-linked Hypophosphatemia (XLH) treated with Burosumab, a fully human monoclonal antibody against FGF23: Final results of a phase 3 trialPeter Kamenický,Anthony A. Portale, Tom Carpenter,Karine Briot,Erik A. Imel,Thomas Weber,Pisit Pitukcheewanont,Hae Il Cheong,Suzanne Jan de Beur,Yasuo Imanishi,Nobuaki Ito,Robin Lachmann,Hiroyuki Tanaka,Farzana Perwad,Lin Zhang,Alison Skrinar,Linda Rees,Karl L. InsognaBone Reports（2020）引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
